Aveanna Healthcare reported Q3 2026 earnings of $0.23 per share, beating consensus estimates of $0.20, with revenues of $695.54 million exceeding expectations by 1.81%. The company has outperformed market estimates in four consecutive quarters and gained 60.2% year-to-date. Aveanna received a Zacks Rank #2 (Buy) rating with favorable estimate revision trends. Meanwhile, Agilent Technologies is expected to report Q3 2026 results on November 23, with projected earnings of $1.72 per share (+8.2% YoY) and revenues of $1.99 billion (+6.7% YoY), though consensus estimates were revised 1% lower in the last 30 days.